Global bioprocess technology market will reach $88.39 billion by 2033, growing by 13.8% annually over 2023-2033. The growth is driven an increasing prevalence of chronic diseases, the widespread use of bioprocess technology, rising expenditures on R&D in the biotechnology sector, ongoing technological advancements, and a rising number of new drug production and launches.
Highlighted with 88 tables and 93 figures, this 189-page report "Global Bioprocess Technology Market 2023-2033 by Product (Instruments, Consumables and Accessories), Process (Upstream, Downstream), Procedure, Application (Recombinant Proteins, Antibiotics, Biosimilars, mAbs, Others), End User (Biopharma Companies, CMOs, Institutes, CROs), and Region: Trend Forecast and Growth Opportunity" is based on comprehensive research of the entire global bioprocess technology market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2021-2023 and provides a forecast from 2024 till 2033 with 2023 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year, and the forecast covers at least 5 years over the base year.)
In-depth qualitative analyses include identification and investigation of the following aspects:
• Market Structure
• Growth Drivers
• Restraints and Challenges
• Emerging Product Trends & Market Opportunities
• Porter's Fiver Forces
The trend and outlook of global market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19 and Russia-Ukraine conflict. The balanced (most likely) projection is used to quantify global bioprocess technology market in every aspect of the classification from perspectives of Product, Process, Procedure, Application, End User, and Region.
Based on Product, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2023-2033 included in each section.
• Instruments
o Bioprocess Analyzers
o Osmometers
o Bioreactors
o Incubators
o Other Instruments
• Consumables and Accessories
o Culture Media
o Reagents
o Other Consumables and Accessories
Based on Process, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2023-2033 included in each section.
• Upstream Bioprocessing
• Downstream Bioprocessing
By Procedure, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2023-2033 included in each section.
• Cell Culture
• Cell Expansion
• Flow Cytometry
• Cell Line Development
• Cell Counting
• Biologics Safety Testing
• Tangential Flow Filtration (TFF)
• Other Procedures
By Application, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2023-2033 included in each section.
• Recombinant Proteins
• Antibiotics
• Biosimilars
• Monoclonal Antibodies (mAbs)
• Other Applications
By End User, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2023-2033 included in each section.
• Biopharmaceutical Companies
• Contract Manufacturing Organizations (CMOs)
• Academic Research Institutes
• Contract Research Organizations (CROs)
• Food & Feed Industry
• Other End Users
Geographically, the following regions together with the listed national/local markets are fully investigated:
• North America (U.S., Canada, and Mexico)
• Europe (Germany, UK, France, Spain, Italy, Netherlands, Rest of Europe; Rest of Europe is further segmented into Russia, Switzerland, Poland, Sweden, Belgium, Austria, Ireland, Norway, Denmark, and Finland)
• APAC (Japan, China, South Korea, Australia, India, and Rest of APAC; Rest of APAC is further segmented into Malaysia, Singapore, Indonesia, Thailand, New Zealand, Vietnam, Taiwan, and Philippines)
• South America (Brazil, Chile, Argentina, Rest of South America)
• MEA (UAE, Saudi Arabia, South Africa, and Rest of MEA)
For each region and country, detailed analysis and annual revenue ($ mn) are available for 2023-2033. The breakdown of all regional markets by country and the breakdown of each national market by Product, Application, and End User over the forecast years are also included.
The report also covers the current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.
Selected Key Players:
Advanced Instruments LLC
Agilent Technologies, Inc.
Becton Dickinson and Company
Bio-rad Laboratories Inc.
Boehringer Ingelheim International GmbH
Catalent Inc.
Charles River Laboratories
Corning Inc.
Danaher Corporation
Elitechgroup Inc. (gonotec Gmbh)
Eppendorf Se
F. Hoffmann-la Roche Ltd.
Fujifilm Healthcare Americas Corporation
GE Healthcare (General Electric Company)
Getinge Ab
Koninklijke Philips N.V.
Lonza Group Ag
Merck Kgaa
Repligen Corp.
Sartorius Group
STADA Arzneimittel AG
Thermo Fisher Scientific Inc.
(Please note: The report will be updated before delivery so that the latest historical year is the base year, and the forecast covers at least 5 years over the base year.)
1 Introduction 10
1.1 Industry Definition and Research Scope 10
1.1.1 Industry Definition 10
1.1.2 Research Scope 11
1.2 Research Methodology 14
1.2.1 Overview of Market Research Methodology 14
1.2.2 Market Assumption 15
1.2.3 Secondary Data 15
1.2.4 Primary Data 15
1.2.5 Data Filtration and Model Design 16
1.2.6 Market Size/Share Estimation 17
1.2.7 Research Limitations 18
1.3 Executive Summary 19
2 Market Overview and Dynamics 22
2.1 Market Size and Forecast 22
2.1.1 Impact of COVID-19 on World Economy 23
2.1.2 Impact of COVID-19 on the Market 27
2.1.3 Impact of Russia-Ukraine Conflict 29
2.1.4 Impact of Israel-Palestine War 31
2.2 Major Growth Drivers 32
2.3 Market Restraints and Challenges 37
2.4 Emerging Opportunities and Market Trends 40
2.5 Porter's Fiver Forces Analysis 44
3 Segmentation of Global Market by Product 48
3.1 Market Overview by Product 48
3.2 Instruments 50
3.2.1 Bioprocess Analyzers 52
3.2.2 Osmometers 53
3.2.3 Bioreactors 54
3.2.4 Incubators 55
3.2.5 Other Instruments 56
3.3 Consumables and Accessories 57
3.3.1 Culture Media 59
3.3.2 Reagents 60
3.3.3 Other Consumables and Accessories 61
4 Segmentation of Global Market by Process 62
4.1 Market Overview by Process 62
4.2 Upstream Bioprocessing 64
4.3 Downstream Bioprocessing 65
5 Segmentation of Global Market by Procedure 66
5.1 Market Overview by Procedure 66
5.2 Cell Culture 68
5.3 Cell Expansion 69
5.4 Flow Cytometry 70
5.5 Cell Line Development 71
5.6 Cell Counting 72
5.7 Biologics Safety Testing 73
5.8 Tangential Flow Filtration (TFF) 74
5.9 Other Procedures 75
6 Segmentation of Global Market by Application 76
6.1 Market Overview by Application 76
6.2 Recombinant Proteins 78
6.3 Antibiotics 79
6.4 Biosimilars 80
6.5 Monoclonal Antibodies (mAbs) 81
6.6 Other Applications 82
7 Segmentation of Global Market by End User 83
7.1 Market Overview by End User 83
7.2 Biopharmaceutical Companies 85
7.3 Contract Manufacturing Organizations (CMOs) 86
7.4 Academic Research Institutes 87
7.5 Contract Research Organizations (CROs) 88
7.6 Food & Feed Industry 89
7.7 Other End Users 90
8 Segmentation of Global Market by Region 91
8.1 Geographic Market Overview 2023-2033 91
8.2 North America Market 2023-2033 by Country 95
8.2.1 Overview of North America Market 95
8.2.2 U.S. 99
8.2.3 Canada 102
8.2.4 Mexico 104
8.3 European Market 2023-2033 by Country 106
8.3.1 Overview of European Market 106
8.3.2 Germany 110
8.3.3 U.K. 112
8.3.4 France 114
8.3.5 Spain 116
8.3.6 Italy 118
8.3.7 Netherlands 120
8.3.8 Rest of European Market 122
8.4 Asia-Pacific Market 2023-2033 by Country 124
8.4.1 Overview of Asia-Pacific Market 124
8.4.2 Japan 128
8.4.3 China 131
8.4.4 Australia 133
8.4.5 India 135
8.4.6 South Korea 137
8.4.7 Rest of APAC Region 139
8.5 South America Market 2023-2033 by Country 141
8.5.1 Argentina 144
8.5.2 Brazil 146
8.5.3 Chile 148
8.5.4 Rest of South America Market 150
8.6 MEA Market 2023-2033 by Country 151
8.6.1 UAE 154
8.6.2 Saudi Arabia 156
8.6.3 South Africa 158
8.6.4 Other National Markets 160
9 Competitive Landscape 161
9.1 Overview of Key Vendors 161
9.2 New Product Launch, Partnership, Investment, and M&A 165
9.3 Company Profiles 166
Advanced Instruments LLC 166
Agilent Technologies, Inc. 168
Becton Dickinson and Company 169
Bio-rad Laboratories Inc. 170
Boehringer Ingelheim International GmbH 171
Catalent Inc. 172
Charles River Laboratories 173
Corning Inc. 174
Danaher Corporation 175
Elitechgroup Inc. (gonotec Gmbh) 176
Eppendorf Se 177
F. Hoffmann-la Roche Ltd. 178
Fujifilm Healthcare Americas Corporation 179
GE Healthcare (General Electric Company) 180
Getinge Ab 181
Koninklijke Philips N.V. 182
Lonza Group Ag 183
Merck Kgaa 184
Repligen Corp. 185
Sartorius Group 186
STADA Arzneimittel AG 187
Thermo Fisher Scientific Inc. 188
RELATED REPORTS 189
The Nanobubble Technology Solution Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landscape, manu...
The Industrial Drone Technology Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landscape, manufac...
Market Overview
The Asia Pacific AI-Enabled Biometric Market is set to experience robust growth from 2024 to 2034, driven by the increasing adoption of artificial intelligence (AI) technologies in biometric systems to enhance security, identity verification, and surveillance. The market...
Market Overview
The Europe AI-Enabled Biometric Market is expected to experience substantial growth from 2024 to 2034, driven by the rising demand for enhanced security systems, increasing adoption of artificial intelligence (AI) technologies, and the need for more efficient biometric i...
Market Overview
The North America AI-Enabled Biometric Market is projected to experience substantial growth from 2024 to 2034, driven by the increasing demand for advanced, secure, and convenient identity verification solutions across various sectors. With rising adoption in areas such ...
Market Overview
The Global AI-Enabled Biometric Market is anticipated to experience substantial growth from 2024 to 2034, propelled by advancements in artificial intelligence, increasing security concerns, and the need for more accurate and efficient identity verification methods. In 20...
Market Overview
The Asia Pacific Passive Optical Network (PON) Market is poised for robust growth between 2024 and 2034, driven by the increasing demand for high-speed broadband connectivity, especially in emerging economies. The market is expected to reach USD XX.XX billion by 2034, gr...
Market Overview
The Europe Passive Optical Network (PON) Market is anticipated to experience significant growth from 2024 to 2034, driven by the increasing demand for high-speed internet, data services, and the transition towards fiber-based broadband solutions. As fiber-optic networks ...
Market Overview
The North America Passive Optical Network (PON) Market is set to experience substantial growth from 2024 to 2034, fueled by increasing investments in fiber-optic infrastructure and growing demand for high-speed, reliable internet connectivity. Projected to reach USD XXX....
Market Overview
The Global Passive Optical Network (PON) Market is anticipated to experience robust growth from 2024 to 2034, driven by increasing demand for high-speed internet and data transmission solutions across residential and commercial sectors. In 2024, the market is valued at U...